← All organizations

Hugel

For profitContributed to NMEWebsite ↗

Also known as: Hugel | Hugel, Inc. | HUGEL INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Feb 29, 2024

Defunct as of Jan 1, 2018

Timeline

2000s

Jun 1, 2001
Hugel— Founded

2010s

Jan 1, 2018
Hugel— Defunct

2020s

Feb 29, 2024
letibotulinumtoxina— NDA Organization

Drugs by trial phase (4 distinct, 15 trials)

Phase 4 (1 own, 0 via acquisition)

onabotulinumtoxinA

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

bmt101

Indications

Studied for

Marketed drugs (1)

letibotulinumtoxina

Recent trials (15)

NCT05801146Lead sponsorPhase 3Nov 30, 2023
NCT04944953Lead sponsorPhase 1Jun 11, 2021
NCT04443244Lead sponsorPhase 2May 27, 2020
NCT04763265CollaboratorPhase 2Dec 18, 2019
NCT04171258Lead sponsorPhase 1Nov 30, 2019
NCT04186442Lead sponsorPhase 1Oct 28, 2019
NCT04012099Lead sponsorPhase 2Aug 1, 2019
NCT03408236Lead sponsorPhase 3Sep 11, 2017
NCT05380154Lead sponsorPhase 3May 9, 2017
NCT03133130Lead sponsorPhase 1Apr 1, 2017
NCT03641950Lead sponsorPhase 4Apr 30, 2015
NCT01915459Lead sponsorPhase 3Jun 1, 2013
NCT01787344Lead sponsorPhase 3Mar 1, 2012
NCT01791920Lead sponsorPhase 3Aug 1, 2011
NCT01791881Lead sponsorPhase 3Apr 1, 2008

Details

Founded: Seoul, KR Jun 1, 2001
First NDA: Feb 29, 2024
Last known activity: Feb 29, 2024